https://www.selleckchem.com/pr....oducts/Belinostat.ht
Here, we report the first FLVCR1a reliable protocol suitable for both antibody generation and structural characterisation. OBJECTIVE The aim of this study was to determine the success rate of sEEG in locating the epileptogenic zone (EZ) in patients with pharmaco-resistant epilepsy. Secondary objectives were to analyze sEEG-related morbidity and outcomes for post-sEEG thermocoagulation and cortical resection. METHODS Data were collected on 49 sEEGs from 46 consecutive patients between 2010 and 2018. Following sEEG, either resective or